With the acquisition of Medicus Health, Doctolib is not only expanding its European presence to a fifth market. The French group is especially making its entry into the United Kingdom, one of the most complex and locked environments on the continent in the field of medical software for general practitioners, and historically dominated for more than twenty years by a solidly established quasi-duopoly.
The United Kingdom constitutes a special case in European digital health, the General Practitioners system, the backbone of British primary care, is based on software infrastructures deeply integrated into the functioning of NHS England. The software used by practices is not only used to manage diaries or patient files, but also orchestrates prescriptions, reimbursements, exchanges of medical data, administrative flows and all interactions with health authorities.
In this context, acquired positions are extremely difficult to dislodge. Two players largely dominate the market, Optum, a subsidiary of the American giant UnitedHealth Group, and TPP. Their historical presence gives them a considerable structural advantage with deep technical integration, regulatory control, user inertia and operational dependence on medical practices.
And it is precisely this wall that Doctolib is today seeking to get around. The central element of the operation lies in the validation obtained by Medicus from the NHS in June 2025. This certification is much more than simple regulatory approval, it constitutes the essential entry point for accessing the British primary care market. Without the latter, entering the market would have required several years of development, integration and technical negotiations.
By purchasing Medicus, Doctolib is therefore acquiring less of a startup with around twenty employees than of a strategic position in the NHS software ecosystem. An acquisition that makes sense in the evolution of the group which now seeks to become a complete publisher of software for healthcare professionals.
The company today develops practice management tools, patient files, billing solutions, teletransmission systems, consultation assistants and telephone tools, to which are now added artificial intelligence building blocks intended to automate certain administrative and clinical tasks.
The United Kingdom thus becomes a strategic laboratory for Doctolib, and the group announces that it intends to invest more than 100 million pounds sterling in the coming years, in particular in the opening of a research and development center dedicated to primary care, and the recruitment of 150 people.
This acquisition comes in a particularly tense context for the NHS. The British system is facing increasing pressure linked to the shortage of general practitioners, the saturation of practices, the increase in administrative tasks and the aging of the population. In this context, automation is gradually becoming a structural issue to maintain the operational capacity of primary care.
The operation also reveals a broader evolution of the European healthtech sector. After a decade dominated by medical marketplaces and teleconsultation, the battle is now being played out in the invisible layers of healthcare organization: business software, clinical workflows, administrative automation and medical data infrastructures.
